Richard Bambury MDAttending Physician, Department of Genitourinary Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York
Dr. Bambury graduated from University College Cork, Ireland, and underwent residency training in Internal Medicine with the Royal College of Physicians Ireland. He subsequently completed medical oncology training with fellowships at Memorial Sloan Kettering Cancer Center, New York and the Royal College of Physicians, Ireland. He is currently an attending physician in the Faculty of Genitourinary Oncology at MSKCC.
Dr. Bambury has been involved in a wide range of clinical and translational research projects with peer-reviewed publications in bladder cancer, prostate cancer, colorectal cancer, breast cancer and glioblastoma. He is the recipient of a number of awards including the 2011 Irish Society of Medical Oncology Scholarship, the 2012 Ainsworth Scholarship and the 2013 John Quale Travel Fellowship. His current research is focused on developing novel treatments for prostate and bladder cancer with a specific focus on the concurrent development of companion predictive biomarkers or response.
Recent Contributions to PracticeUpdate:
- Opportunistic Testing vs Organized PSA Screening
- Dr. Richard Bambury Reports: 2015 Genitourinary Cancers Symposium
- mRNA Biomarkers Predictive for Outcome in Childhood Neuroblastoma
- Peritoneal Carcinomatosis Less Frequently Diagnosed During Laparoscopic vs Open Surgery for CRC
- Benefit From Alkylating-Agent Chemotherapy in Oligodendrogliomas Associated With IDH Mutation
- Histologic Subtype Strongly Influences Patterns of Metastasis in CRC
- Hyperfractionated Radiotherapy Improves Survival in Head and Neck Cancer Patients